Excedrin and Nabumetone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Excedrin (acetaminophen; aspirin; caffeine) and Nabumetone (nabumetone). Common drug interactions include hallucination among females.

The phase IV clinical study analyzes what interactions people have when they take Excedrin and Nabumetone. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.

What is Excedrin?

Excedrin has active ingredients of acetaminophen; aspirin; caffeine. It is often used in headache. eHealthMe is studying from 22,740 Excedrin users. Check the latest studies of Excedrin.

What is Nabumetone?

Nabumetone has active ingredients of nabumetone. It is often used in arthritis. eHealthMe is studying from 9,554 Nabumetone users. Check the latest studies of Nabumetone.



On Jul, 19, 2026

30 people who take Excedrin and Nabumetone together, and have interactions are studied.

Excedrin and Nabumetone drug interactions.

What are the common drug interactions of Excedrin and Nabumetone, by gender? *:

female:

  1. Hallucination (an experience involving the perception of something not present)
  2. Thrombosis (formation of a blood clot inside a blood vessel)
  3. Abdominal pain
  4. Appendicitis (inflammation of the appendix)
  5. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
  6. Cellulitis (infection under the skin)
  7. Cholecystitis chronic (long lasting infection of gallbladder)
  8. Dehydration (dryness resulting from the removal of water)
  9. Gallbladder disorder
  10. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)

male:

n/a

What are the common drug interactions of Excedrin and Nabumetone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Abdominal pain
  2. Appendicitis (inflammation of the appendix)
  3. Cholecystitis chronic (long lasting infection of gallbladder)
  4. Coagulopathy (blood's ability to clot is impaired)
  5. Gallbladder disorder
  6. Dysphagia (a condition in which swallowing is difficult or painful)
  7. Dyspnoea (difficult or laboured respiration)
  8. Muscle spasms (muscle contraction)
  9. Muscle twitching
  10. Pain in jaw

20-29:

  1. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  2. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  3. Pulmonary embolism (blockage of the main artery of the lung)

30-39:

n/a

40-49:

  1. Malaise (a feeling of general discomfort or uneasiness)
  2. Nausea (feeling of having an urge to vomit)
  3. Vomiting
  4. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  5. Oesophageal candidiasis (fungal infection of oesophagus)
  6. Adverse drug reaction
  7. Anxiety
  8. Depression
  9. Dizziness
  10. Fibromyalgia (a long-term condition which causes pain all over the body)

50-59:

  1. Visual impairment
  2. Vomiting
  3. Cellulitis (infection under the skin)
  4. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
  5. Gallbladder operation
  6. Muscle spasms (muscle contraction)
  7. Nausea (feeling of having an urge to vomit)
  8. Pain in extremity
  9. Skin burning sensation
  10. Suicidal ideation

60+:

  1. Coagulopathy (blood's ability to clot is impaired)
  2. Haemorrhagic stroke (stroke caused by the rupture of a blood vessel in the brain)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 9 people, 30.00%
  2. Fibromyalgia (a long-term condition which causes pain all over the body): 5 people, 16.67%
  3. Drowsiness: 5 people, 16.67%
  4. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 16.67%
  5. High Blood Cholesterol: 3 people, 10.00%
  6. Sick Sinus Syndrome (a collection of heart rhythm disorders): 2 people, 6.67%
  7. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 6.67%
  8. Psoriasis (immune-mediated disease that affects the skin): 2 people, 6.67%
  9. Muscle Disorder (muscle disease): 2 people, 6.67%
  10. Migraine (headache): 2 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Excedrin and Nabumetone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Excedrin and Nabumetone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Excedrin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Nabumetone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Excedrin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nabumetone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on acetaminophen; aspirin; caffeine and nabumetone (the active ingredients of Excedrin and Nabumetone, respectively), and Excedrin and Nabumetone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: